Haorou Luo
Lixue Yin- 1Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China
- 2Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, School of Medicine University of Electronic Science and Technology of China (UESTC), Chengdu, Sichuan, China
Objective: Superb micro-vascular imaging (SMI) is a new noninvasive modality for the diagnosis of thyroid nodules. However, the performance of SMI in differentiating malignant and benign thyroid nodules has not been systematically evaluated. This meta-analysis was performed to assess the accuracy of SMI in diagnosing thyroid nodules.
Methods: PubMed, Cochrane Library, Embase, Web of Science, Sinomed, Scopus were searched. We recorded the characteristics of the included studies and assessed the quality of each study using the QUADAS-2 tool. The pooled sensitivity, specificity, positive likelihood ratio (LR), negative LR, diagnostic odds ratio (DOR), and area under the curve (AUC) were calculated. We also evaluated the publication bias.
Results: This meta-analysis included 10 studies with a total of 1083 thyroid nodules. The pooled the sensitivity, specificity, and positive and negative LR were 0.84, 0.86, 6.2, and 0.18, respectively. The DOR and AUC were 33 and 0.91, respectively. Heterogeneity existed between the included studies. No significant publication bias was observed.
Conclusion: Compared with CDFI, Superb micro-vascular imaging (SMI) has higher diagnostic sensitivity and specificity, better diagnostic efficiency, and could be used to diagnose benign and malignant nodules in the display of blood flow distribution capabilities of thyroid nodules; at the same time, Fagan plot showed that the SMI technique had a good clinical application value, and it could supplement the deficiencies of color Doppler imaging in the diagnosis of thyroid nodules.
Introduction
Thyroid nodules are discrete lesions in the thyroid gland that are distinct from the surrounding parenchyma (1). Recently, the incidence of thyroid nodule has been increasing year by year, making it one of the most common diseases of the thyroid system, with occult thyroid nodule accounting for 65% of the total population (2). According to the report, approximately 5% of thyroid nodules are at risk of developing thyroid cancer (3), with thyroid carcinoma becoming the most common tumour in the head and neck region (4). In clinical practice, ultrasound is the most sensitive imaging method for diagnosing thyroid nodules (5). According to research, it is necessary to evaluate the blood supply in thyroid nodules and distinguish benign from malignant nodules (6).
As a new angiography technology, superb microvascular imaging (SMI) can visualise low-speed blood flow and depict vascular flow in more detail than colour Doppler flow imaging, allowing for higher-quality microvascular flow images without the use of contrast media (7, 8). In recent years, with the widespread use of SMI technology in breast, liver and other fields, an increasing number of research teams have begun to pay attention to the diagnostic value of SMI in thyroid nodules. Despite numerous studies comparing ultrasound microangiography to conventional two-dimensional ultrasound diagnosis, there are still internal debates regarding the comparison of sensitivity, specificity and other indicators. Therefore, in order to provide a relatively objective and comprehensive evidence-based diagnostic basis for clinical thyroid management, this study collected all relevant literatures from both domestic and international sources, summarised the data of the two diagnostic methods using meta-analysis and comprehensively compared the diagnostic efficacy with pathological diagnosis as the reference standard.
Review methods
This present study has been conducted and reported in accordance with the PRISMA statement. Institutional review board approval was not required as our study was a meta-analysis and consent was not required for this research.
Literature search
We conducted a comprehensive search of all literatures in PubMed, Cochrane Library, Embase, Web of Science, Sinomed, Scopus and other databases until January 2021. Searches were conducted using the following MeSH heading and key words: “thyroid nodules[MeSH] OR thyroid disease OR thyroid” and”Superb Microvascular Imaging OR SMI”. In order to expand the scope of our search, we also screened the references of the retrieved articles. Language restrictions are not applied.
Inspection methods and study selection
Routine two-dimensional ultrasonography was performed on the patients, and the thyroid nodule was observed in terms of boundary, size, internal echo, morphology, calcification, etc., and was preliminarily classified according to the TI-RADS classification system (1). Superb Microvascular Imaging (SMI) and color Doppler flow imaging (CDFI) were used to evaluate the nodules on the basis of conventional two-dimensional imaging. The blood supply and blood flow distribution pattern of the nodules were mainly evaluated. The classification standard of blood flow distribution pattern was based on Kim semi-quantitative method (9), and the blood flow signal grading was based on Adler classification method (10).
The selection of the literature by the two personnel was carried out according to the inclusion and exclusion criteria for diagnostic trials recommended by Cochrane. The process was ensured to be independent and separate. Finally, the two data were obtained, and then the data were cross-checked.
Inclusion criteria: (1) The pathological diagnosis results were considered as the “gold standard”, and the disease diagnosis was clear; (2) Subjects included patients with thyroid nodule with other diseases, whose nature was not defined before thyroid nodule examination; (3) Data sample size ≥30 cases; (4) Microangiography and conventional two-dimensional ultrasonography were in the same group; (5) The literatures of TP, FP, FN and TN can be directly extracted or indirectly calculated according to sensitivity, specificity and number of cases.
Exclusion criteria: (1) No literature on pathological diagnosis; (2) Literature that was directly included in the study with cases after diagnosis; (3) Reviews, conferences, case reports; (4) Incomplete data, TP, FP, FN and TN cannot be directly extracted or indirectly calculated according to sensitivity, specificity and number of cases; (5) Duplicate literature searched in different databases.
Data extraction and quality assessment
The data for qualified full-text articles were independently extracted by two researchers (Haorou, Luo and Lixue, Yin), and different comments were solved by discussion and consensus. The recorded data are as follows: First author, language, year, mean age of patients, number of malignant lesions, “gold standard” diagnosis, type of study. The diagnostic trials were analyzed according to the Cochrane recommended diagnostic accuracy study quality assessment tool (QUADAS-2) (11), and then the risk of bias and clinical applicability were evaluated summatively.
Statistical analyses
The heterogeneity of the included literatures were evaluated using the inconsistency index (I2) and Cochrane Q-tests(x2). If I2 > is 50% or P < 0.10, high heterogeneity exists among the results. I2 < 25% indicates that there is little heterogeneity among the results. 25%≤I2 ≤ 50%, indicating moderate heterogeneity of the results. At the same time, the Bivariate boxplot can be used to make rough judgment, and then guide the sensitivity analysis. If the heterogeneity result is large, try to trace the source of heterogeneity by means of meta-regression. The positive likelihood ratio, negative likelihood ratio, sensitivity, specificity and diagnostic odds ratio of the two methods were analyzed and compared, and then the SROC curve was drawn. Sensitivity analysis and meta-regression subgroup analysis were performed. Deek funnel plot was drawn to evaluate whether there was publication bias, and the funnel plot was observed to be symmetrical, combined with P value to make a comprehensive evaluation. Fagan plot can show the correlation between prior probability, likelihood ratio and post-test probability. The greater the difference between prior and post-test probability, the more important the diagnostic test is, and it can provide a reference for clinical application evaluation. All analyses were completed using StataV 15.0.
Results
Literature search and selection
As shown in Figure 1, the initial search yielded 684 records. 229 records were excluded after removing duplicates. and 400 were excluded after screening the titles and abstracts. Depending on the inclusion and exclusion criteria, 45 records were deleted, ten studies ultimately are included in our meta-analysis (12–21).
Figure 1 Flowchart of study search.
Study characteristics
The included 10 records included patients who were examined by both ultrasound microvascular imaging and color Doppler blood flow imaging, with a total of 1083 lesions, of which 518 were malignant lesions. Details of the eligible studies are shown in Table 1. All of them were diagnostic studies published from 2016 through 2020, 5 of which were recorded in Chinese and 5 in English; Nine records were prospective studies, and only one record was retrospective studies; The gold standard for all the selected studies was pathological tissue study, of which 3 records were surgical pathology plus fine needle aspiration pathology. The average age of all included patients was under 55. The number of lesions varied from 45 to 254, and the number of patients varied from 34 to 241.
Table 1 characteristics of the included studies.
Quality assessment
The quality assessment of the included studies were evaluated as follows (Table 2). All included studies were in compliance with the index test standards, with pathological evaluation as the reference standard.
Table 2 Quality assessment of the included studies using QUADAS-2 tool.
Diagnostic performance
Random-effects model was used to generate the pooled result. The pooled sensitivity, specificity, positive LR, and negative LR of SMI in differentiating malignant and benign thyroid nodules were 0.84 (95% confidence interval [CI], 0.79-0.88), 0.86 (95% CI, 0.80-0.91), 6.2 (95% CI, 4.1-9.2), and 0.18 (95% CI, 0.14-0.24), respectively. The area under the curve (AUC) was 0.91 (Figure 2). The forest plots of sensitivity, specificity, positive LR, negative LR, and DOR of the included studies were described in Figures 3–5. The detailed comparison of the combined effect size SMI and color Doppler was shown in Table 3.
Figure 2 SROC curve and 95% confidence region.
Figure 3 Forest plot for sensitivity and specificity.
Figure 4 Forest plot for Positive likelihood ratio and negative likelihood ratio.
Figure 5 Forest plot for Odds ratio.
Table 3 Comparison of combined effects.
Heterogeneity analyses
When all 10 included studies were analyzed, heterogeneity was found both in sensitivity (heterogeneity, Q=14.26, p =0.11; I2 = 36.88) and specificity (heterogeneity, Q =38.90, p < 0.0001; I2 = 76.86%). To trace the sources of heterogeneity, we primarily analyzed the threshold effect. But there was no shoulder-arm sign shown on the sROC space (Figure 2), and the Spearman correlation coefficient was 0.349 (P=0.324), indicating that all records had no significant threshold effect, and the effect size could be combined. It also indicated that there were other factors leading to heterogeneity in the inclusion analysis. The results of the subgroup analyses showed in Table 4. For the bivariate box chart, the documents outside the central area were deleted and then meta-analysed. It was found that the combined effect of various indicators had little change, indicating that the included documents were stable
Table 4 Meta regression analysis results.
Publication bias
By Deeks’ funnel plot asymmetry test, we found there was no significant publication bias among the eligible studies (P = 0.43). The Deeks’ funnel plot was shown in Figure 6.
Figure 6 Deek’s funnel plot of publication bias.
Clinical application evaluation
According to Fagan’s plot, the post-test probability of SMI was significantly higher than that of CDFI (Figure 7).
Figure 7 Fagan’s plot (A. SMI; B. CDFI).
Discussion
Thyroid nodules have been detected in up to 65% of the total population, indicating that thyroid nodules have become a very common disease (22). The majority of nodules detected by us are benign and can be safely managed through monitoring procedures. The purpose of initial screening and long-term follow-up of thyroid nodules is to better manage the most critical thyroid malignancies (2).
Fine needle aspiration biopsy has always been used to determine the nature of nodules related to clinical malignancies, and its status as the gold standard is unshakable (23). However, routine physical examination requires a non-invasive diagnostic method to assess the characteristics of blood flow distribution and understand the characteristics of blood supply in order to guide puncture (24).
Thyroid ultrasound is considered to be the best imaging method for assessing thyroid nodules or diffuse disease (25), Over the past 25 years, significant advances have been made in the evaluation of the thyroid by ultrasound and in the identification of suspicious and non-suspicious thyroid nodules (26). However, in general, the current conventional color Doppler blood flow imaging still has the disadvantages of insufficient accuracy, a large number of misdiagnosis, and missed diagnosis in the identification of the nature of thyroid nodules. And there are technical limitations to detecting small blood vessels and low blood flow.
Angiogenesis and the growth of irregular vascular structures have been established as the salient features of malignancy. Several previously published studies had shown that peri-nodular blood flow was more associated with benign thyroid nodules, while intra - nodular blood flow tended to be present in malignancies. Therefore, changes in vascular characteristics may provide more valuable diagnostic clues (9, 27).
In recent years, the rapid development of Superb micro-vascular imaging aimed at the deficiency of two-dimensional gray scale ultrasound and color Doppler blood flow imaging, and provided information about low speed blood flow, detection of small vessels (8). It reveals more microvascular branches, and shows the blood flow distribution in the nodules and adjacent thyroid parenchyma in more detail, which has become a more effective detection method (28). Although Superb micro-vascular imaging could be used to distinguish malignant and benign thyroid nodules, the value of its differential diagnosis is still inconclusive, and there is currently no Meta-analysis on the diagnostic performance of SMI technology. Therefore, the method of systematic review in this study was adopted to compare the value of SMI and CDFI in differentiating benign and malignant thyroid nodules. To provide an exact evidence-based basis for the differential diagnosis of benign and malignant thyroid nodules by SMI technology, so as to better guide the clinical diagnosis and treatment.
The pooled results showed that SMI could diagnose thyroid nodules, and the pooled sensitivity, specificity, positive LR and negative LR values were 0.84, 0.86, 6.2, and 0.18, respectively. These results indicated SMI had high sensitivity and specificity in diagnosing thyroid nodules. The AUC was 0.91, and the DOR was 33, which were the overall evaluation indicators of diagnostic tests, which proved the high accuracy of SMI in the differentiation of thyroid malignant nodules and benign nodules.
The heterogeneity test of our study showed moderate heterogeneity. We discovered that there was no significant threshold effect among the included records. Therefore, subgroup analyses were performed to find the source of heterogeneity. The results of the subgroup analyses showed that the heterogeneity of the combined estimates was reduced after excluding the Chinese study. The reassessed pooled results still suggested that SMI was more accurate in the diagnosis of thyroid nodules (AUC = 0.91, DOR = 32). In the 10 literatures included in this paper, although the “gold standard” was pathological examination, some were surgical biopsy histological pathology and some were cell puncture pathological results, which may also be one of the sources of heterogeneity.
Limitations of our meta-analysis: (1). Only 10 records were included in our meta-analysis. A small number of studies might reduce the effectiveness of the tests of heterogeneity and publication bias. (2). Different diagnostic criteria were used in the included studies, and neither of the two diagnostic methods was quantified and there was no unified diagnostic standard.
In conclusion, Superb micro-vascular imaging (SMI) is more sensitive, specific and effective than color doppler flow imaging in differentiating malignant and benign thyroid nodules. At the same time, SMI has good clinical value and can supplement the deficiency of CDFI in the diagnosis of thyroid nodule. SMI technology could truly reflect the blood flow distribution without the presence of blood flow signal spillover, and could be very sensitive to detect low blood flow and small blood vessels. Meanwhile, the examination cost is low, and compared with other imaging examinations, SMI technology has the advantages of non-trauma and non-radiation.
At present, as an emerging diagnostic technology, SMI still needs to develop a more detailed classification evaluation to quantify the form of blood flow distribution. At the same time, a unified diagnostic standard is also needed to guide clinical diagnosis, treatment and prognosis, To better tap the application potential of SMI diagnosis, future large-scale, controlled, multicenter studies are recommended.
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Author contributions
HL: conception and design, acquisition of data, analysis and interpretation of data, drafting and revising the article; final approval of the version to be published. LY: the corresponding author of this paper, acquisition of data, analysis and interpretation of data. revise the article. All authors contributed to the article and approved the submitted version.
Funding
Funding: The fundamental Research Funds for the central Universities, Grant/Award Number: ZYGX2020ZB038. Funding belongs to the corresponding author’s laboratory.
Acknowledgments
The authors express their gratitude to Sichuan provincial people’s hospital and UESTC for their cooperation and assistance.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Abbreviations
SMI, superb microvascular imaging; CDFI, color doppler flow imaging; DOR, diagnostic odds ratio; AUC, area under the curve; ROC, receiver operating curve; CI, confidence interval.
References
1. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid (2016) 26(1):1–133. doi: 10.1089/thy.2015.0020
2. Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The diagnosis and management of thyroid nodules: A review. Jama (2018) 319(9):914–24. doi: 10.1001/jama.2018.0898
3. Grani G, Sponziello M, Pecce V, Ramundo V, Durante C. Contemporary thyroid nodule evaluation and management. J Clin Endocrinol Metab (2020) 105(9):2869–83. doi: 10.1210/clinem/dgaa322
4. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the united states, 1974-2013. Jama (2017) 317(13):1338–48. doi: 10.1001/jama.2017.2719
5. Iwen A. [Ultrasound examination of the thyroid gland - step by step]. Dtsch Med Wochenschr (2020) 145(4):260–7. doi: 10.1055/a-0674-7845
6. Cansu A, Ayan E, Kul S, Eyüboğlu İ, Oğuz Ş, Mungan S. Diagnostic value of 3D power Doppler ultrasound in the characterization of thyroid nodules. Turk J Med Sci (2019) 49(3):723–9. doi: 10.3906/sag-1803-92
7. Ma Y, Li G, Li J, Ren WD. The diagnostic value of superb microvascular imaging (SMI) in detecting blood flow signals of breast lesions: A preliminary study comparing SMI to color Doppler flow imaging. Med (Baltimore) (2015) 94(36):e1502. doi: 10.1097/MD.0000000000001502
8. Machado P, Segal S, Lyshchik A, Forsberg F. A novel microvascular flow technique: Initial results in thyroids. Ultrasound Q (2016) 32(1):67–74. doi: 10.1097/RUQ.0000000000000156
9. Kim DW, In HS, Choo HJ, Jung SJ, Kim YW. Solid and isoechoic thyroid nodules without malignant sonographic features: comparison of malignancy rate according to nodule size, shape and color Doppler pattern. Ultrasound Med Biol (2013) 39(2):269–74. doi: 10.1016/j.ultrasmedbio.2012.09.018
10. Adler DD, Carson PL, Rubin JM, Quinn-Reid D. Doppler Ultrasound color flow imaging in the study of breast cancer: Preliminary findings. Ultrasound Med Biol (1990) 16(6):553–9. doi: 10.1016/0301-5629(90)90020-D
11. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol (2003) 3:25. doi: 10.1186/1471-2288-3-25
12. Tian J, Yong Q, Li C. Preliminary study on the application value of ultramicroangiography in differentiating benign and malignant thyroid nodules. Cancer progression (2017) 15(04):450–3.doi: 10.11877/j.issn.1672-1535.2017.15.04.28
13. Ou Y. Study on the value of microangiography and contrast-enhanced ultrasound in differentiating benign and malignant thyroid nodule. Chin J Ultrasound Med (2017) 4(33):293–6. doi: 10.3969/j.issn.1002-0101.2017.04.003
14. Diao X, Zhan J, Chen L, Chen Y, Cao H. Application value of super microangiography in differential diagnosis of solid thyroid nodules. Chin J Med Ultrasound (2016) 16(08):622–6. doi: 10.3877/cma.j.issn.1672-6448.2016.08.013
15. Yang H, Zhang L, Li H. Analysis of the value of super microangiography in the differential diagnosis of solid thyroid nodules. J Clin Exp Med (2017) 16(10):1029–32. doi 10.3969/j.issn.1671-4695.2017.10.030
16. Wang H, Qiu J, Luo S. Evaluation of benign and malignant thyroid nodules by grayscale model microangiography. J Appl Radiol (2020) 5(36):714–7. doi: 10.3969/j.issn.1002-1671.2020.05.007
17. Li Y, Wen D, Li C, Li XJ, Xue G. The role of ATA (2015) guidelines, superb microvascular imaging, and spectral Doppler in differentiation between malignant and benign thyroid nodules. Lin chuang er bi yan hou tou jing wai ke za zhi= J Clin otorhinolaryngol head Neck Surg (2017) 31(15):1152–6. doi: 10.13201/j.issn.1001-1781.2017.15.003
18. Kong J, Li J-C, Wang H-Y, Wang YH, Zhao RN, Zhang Y, et al. Role of superb micro-vascular imaging in the preoperative evaluation of thyroid nodules: Comparison with power Doppler flow imaging. J ultrasound Med (2017) 36(7):1329–37. doi: 10.7863/ultra.16.07004
19. Zhu YC, Zhang Y, Deng SH, Jiang Q. A prospective study to compare superb microvascular imaging with grayscale ultrasound and color Doppler flow imaging of vascular distribution and morphology in thyroid nodules. Med Sci Monit (2018) 24:9223–31. doi: 10.12659/MSM.911695
20. Ahn HS, Lee JB, Seo M, Park SH, Choi BI. Distinguishing benign from malignant thyroid nodules using thyroid ultrasonography: Utility of adding superb microvascular imaging and elastography. Radiol Med (2018) 123(4):260–70. doi: 10.1007/s11547-017-0839-2
21. Pei S, Cong S, Zhang B, Liang C, Zhang L, Liu J, et al. Diagnostic value of multimodal ultrasound imaging in differentiating benign and malignant TI-RADS category 4 nodules. Int J Clin Oncol (2019) 24(6):632–9. doi: 10.1007/s10147-019-01397-y
22. Wong R, Farrell SG, Grossmann M. Thyroid nodules: diagnosis and management. Med J Aust (2018) 209(2):92–8. doi: 10.5694/mja17.01204
23. Kovacevic B, Vilmann P. EUS tissue acquisition: From a to b. Endosc Ultrasound (2020) 9(4):225–31. doi: 10.4103/eus.eus_21_20
24. Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda system for reporting thyroid cytopathology: A meta-analysis. Acta cytol (2012) 56(4):333–9. doi: 10.1159/000339959
25. Alexander LF, Patel NJ, Caserta MP, Robbin ML. Thyroid ultrasound: Diffuse and nodular disease. Radiol Clin North Am (2020) 58(6):1041–57. doi: 10.1016/j.rcl.2020.07.003
26. Shaha AR. Comment on "The diagnosis and management of thyroid nodules: A review". Gland Surg (2018) 7(5):424–5. doi: 10.21037/gs.2018.06.01
27. Kim DW, Jung SJ, Eom JW, Kang T. Color Doppler features of solid, round, isoechoic thyroid nodules without malignant sonographic features: a prospective cytopathological study. Thyroid (2013) 23(4):472–6. doi: 10.1089/thy.2012.0238
Keywords: thyroid nodules, superb microvascular imaging, ultrasonography, meta-analysis, SMI = superb microvascular imaging
Citation: Luo H and Yin L (2023) Diagnostic value of superb microvascular imaging and color doppler for thyroid nodules: A meta-analysis. Front. Oncol. 13:1029936. doi: 10.3389/fonc.2023.1029936
Received: 28 August 2022; Accepted: 27 March 2023;
Published: 05 April 2023.
Edited by:
Min Tang, Jiangsu University, ChinaReviewed by:
Weiwei Zhan, Shanghai Jiaotong University School of Medicine, ChinaXiao-Yan Zhang, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, China
Copyright © 2023 Luo and Yin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lixue Yin, yinlixue_cardiac@163.com